Sysmex Corp (6869 JP): Hematology Drives Robust 1Q Performance and Guidance Raise; What Lies Ahead
Sysmex reports strong Q1FY27 result with double-digit growth in key parameters, driven by hematology sales. Despite challenges in China, the...
113 Views
Primer: Sysmex Corp (6869 JP) - Aug 2026
Sysmex is a global leader in the in-vitro diagnostics (IVD) market, with a dominant share in the hematology sector, built on a razor-and-blade...
101 Views
Sysmex (6869 JP): Positioned for Global Index Deletion
Sysmex is a potential delete from a global index in May. The stock has underperformed peers and trades cheaper. There is positioning in the stock....
397 Views
Sysmex Corp (6869 JP): 9MFY26 Revenue Drop on China, Guidance Revised Downwards
Sysmex Corp's revenue dropped 2% YoY in 9MFY26, with China and Japan sales declining. Revised FY26 revenue, operating profit and net profit...
371 Views
Primer: Sysmex (6869 JT) - Dec 2025
Sysmex is a global leader in the in-vitro diagnostics (IVD) market, with a dominant position in the hematology segment and a strong presence in...
315 Views